Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations
- 14 March 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 655, 123995
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
This publication has 19 references indexed in Scilit:
- Novel Applications of an In Vitro Injection Model System to Study Bioperformance: Case Studies with Different Drug ModalitiesJournal of Pharmaceutical Innovation, 2020
- Fast-Acting Insulin Aspart: The Rationale for a New Mealtime InsulinDiabetes Therapy, 2019
- Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical FormulationPharmaceutical Research, 2017
- A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation componentsJournal of Controlled Release, 2015
- Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection siteJournal of Controlled Release, 2014
- Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behaviorActa Biomaterialia, 2013
- Rheology and Confocal Reflectance Microscopy as Probes of Mechanical Properties and Structure during Collagen and Collagen/Hyaluronan Self-AssemblyBiophysical Journal, 2009
- A novel insulin formulation with a more rapid onset of actionDiabetologia, 2008
- Native fibrillar collagen membranes of micron-scale and submicron thicknesses for cell support and perfusionBiomaterials, 2005
- On the interaction between polysaccharides and other macromoleculesBiochimica et Biophysica Acta, 1963